- Home
- OPCH vs ALKS Comparison
OPCH vs ALKS Comparison
Compare OPCH & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPCH
- ALKS
- Stock Information
- Founded
- OPCH N/A
- ALKS 1987
- Country
- OPCH United States
- ALKS Ireland
- Employees
- OPCH N/A
- ALKS N/A
- Industry
- OPCH Medical/Nursing Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- OPCH Health Care
- ALKS Health Care
- Exchange
- OPCH Nasdaq
- ALKS Nasdaq
- Market Cap
- OPCH 5.3B
- ALKS 5.1B
- IPO Year
- OPCH N/A
- ALKS 1991
- Fundamental
- Price
- OPCH $30.68
- ALKS $29.69
- Analyst Decision
- OPCH Strong Buy
- ALKS Buy
- Analyst Count
- OPCH 7
- ALKS 12
- Target Price
- OPCH $35.86
- ALKS $40.00
- AVG Volume (30 Days)
- OPCH 1.5M
- ALKS 1.9M
- Earning Date
- OPCH 07-30-2025
- ALKS 07-23-2025
- Dividend Yield
- OPCH N/A
- ALKS N/A
- EPS Growth
- OPCH N/A
- ALKS N/A
- EPS
- OPCH 1.25
- ALKS 2.09
- Revenue
- OPCH $5,185,122,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- OPCH $13.22
- ALKS N/A
- Revenue Next Year
- OPCH $8.52
- ALKS $4.25
- P/E Ratio
- OPCH $24.44
- ALKS $14.20
- Revenue Growth
- OPCH 16.98
- ALKS N/A
- 52 Week Low
- OPCH $21.39
- ALKS $23.12
- 52 Week High
- OPCH $35.53
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- OPCH 43.18
- ALKS 49.52
- Support Level
- OPCH $29.79
- ALKS $28.67
- Resistance Level
- OPCH $31.22
- ALKS $30.90
- Average True Range (ATR)
- OPCH 0.67
- ALKS 0.73
- MACD
- OPCH -0.13
- ALKS 0.15
- Stochastic Oscillator
- OPCH 32.48
- ALKS 49.79
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.